Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses

Progress in Lipid Research

Volumn 64, Issue , 2016, Pages 123-137

  Martín Acebes, Miguel A ^a   Vázquez Calvo, Ángela ^a   Saiz, Juan Carlos ^a  

^a INIA   (Spain)

Author keywords

Dengue virus; Flavivirus; Infection; Lipid; West Nile virus; Zika virus

Indexed keywords

1,4 BIS(2 CHLOROBENZYLAMINOMETHYL)CYCLOHEXANE; 3,3' (1,4 PHENYLENE)BIS[N [4 (4,5 DIHYDRO 1H IMIDAZOL 2 YL)PHENYL]ACRYLAMIDE]; 3BETA (2 DIETHYLAMINOETHOXY)ANDROST 5 EN 17 ONE; ACETYL COENZYME A CARBOXYLASE INHIBITOR; AMITRIPTYLINE; CERULENIN; DOFEQUIDAR; FATTY ACID; FILIPIN; FUMONISIN B2; IMIPRAMINE; LANCOVUTIDE; LIPID; LIPOCORTIN 5; LYSOPHOSPHATIDYLCHOLINE; METHYL BETA CYCLODEXTRIN; NYSTATIN; PF 429242; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHOLIPID DERIVATIVE; PHOSPHOLIPID RECEPTOR; PROTEINASE INHIBITOR; PYRROLIDINE 2; SPHINGOLIPID; STEROL; THERMOZYMOCIDIN; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; ZARAGOZIC ACID; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE;

AUTOPHAGY; DENGUE; DRUG TARGETING; FLAVIVIRUS; FLAVIVIRUS INFECTION; HOST CELL; IMMUNITY; INFECTION CONTROL; LIFE CYCLE; LIPID METABOLISM; LIPIDOMICS; LIPOGENESIS; MEMBRANE FUSION; PRIORITY JOURNAL; REVIEW; VIRUS ASSEMBLY; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS REPLICATION; WEST NILE VIRUS; ZIKA VIRUS; ANIMAL; DENGUE VIRUS; ENCEPHALITIS; HUMAN; METABOLISM; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALS; DENGUE VIRUS; ENCEPHALITIS; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; HUMANS; LIPID METABOLISM; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLSERINES; SPHINGOLIPIDS; WEST NILE VIRUS; ZIKA VIRUS;

EID: 84991509153     PISSN: 01637827     EISSN: 18732194     Source Type: Journal    
DOI: 10.1016/j.plipres.2016.09.005     Document Type: Review

References (186)

1. [1] Martin-Acebes, M.A., Vazquez-Calvo, A., Caridi, F., Saiz, J.C., Sobrino, F., Lipid involvement in viral infections: present and future perspectives for the design of antiviral strategies. Valenzuela, R., (eds.) Lipid metabolism: InTech, 2013, 291–321.
2. [2] Heaton, N.S., Randall, G., Multifaceted roles for lipids in viral infection. Trends Microbiol. 19 (2011), 368–375.
3. [3] Schneider-Schaulies, J., Schneider-Schaulies, S., Sphingolipids in viral infection. Biol. Chem. 396 (2015), 585–595.
4. [4] Filipe, A., McLauchlan, J., Hepatitis C virus and lipid droplets: finding a niche. Trends Mol. Med. 21 (2015), 34–42.
5. [5] Lorizate, M., Krausslich, H.G., Role of lipids in virus replication. Cold Spring Harb. Perspect. Biol., 3, 2011, a004820.
6. [6] Gould, E.A., Solomon, T., Pathogenic flaviviruses. Lancet 371 (2008), 500–509.
7. [7] Martin-Acebes, M.A., Saiz, J.C., West Nile virus: a re-emerging pathogen revisited. World J. Virol. 1 (2012), 51–70.
8. [8] Mackenzie, J.S., Gubler, D.J., Petersen, L.R., Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10 (2004), S98–109.
9. [9] Guzman, M.G., Harris, E., Dengue. Lancet 385 (2015), 453–465.
10. [10] Patel, H., Sander, B., Nelder, M.P., Long-term sequelae of West Nile virus-related illness: a systematic review. Lancet Infect. Dis. 15 (2015), 951–959.
11. [11] Saiz, J.C., Vazquez-Calvo, A., Blazquez, A.B., Merino-Ramos, T., Escribano-Romero, E., Martin-Acebes, M.A., Zika virus: the latest newcomer. Front. Microbiol., 2016.
12. [12] Heinz, F.X., Stiasny, K., Flaviviruses and flavivirus vaccines. Vaccine 30 (2012), 4301–4306.
13. [13] Kiran, S.K., Pasi, A., Kumar, S., Kasabi, G.S., Gujjarappa, P., Shrivastava, A., et al. Kyasanur Forest disease outbreak and vaccination strategy, Shimoga District, India, 2013–2014. Emerg. Infect. Dis. 21 (2015), 146–149.
14. [14] Ishikawa, T., Yamanaka, A., Konishi E. 2014, A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available, Vaccine.
15. [15] Kok, W.M., New developments in flavivirus drug discovery. Expert Opin. Drug Discovery, 2016.
16. [16] Kilpatrick, A.M., Globalization, land use, and the invasion of West Nile virus. Science 334 (2011), 323–327.
17. [17] Gould, E.A., Higgs, S., Impact of climate change and other factors on emerging arbovirus diseases. Trans. R. Soc. Trop. Med. Hyg. 103 (2009), 109–121.
18. [18] Rico-Hesse, R., Dengue virus virulence and transmission determinants. Curr. Top. Microbiol. Immunol. 338 (2010), 45–55.
19. [19] Lambrechts, L., Scott, T.W., Gubler, D.J., Consequences of the expanding global distribution of Aedes albopictus for dengue virus transmission. PLoS Negl. Trop. Dis., 4, 2010, e646.
20. [20] Jansen, C.C., Beebe, N.W., The dengue vector Aedes aegypti: what comes next. Microbes Infect. 12 (2010), 272–279.
21. [21] Lanciotti, R.S., Roehrig, J.T., Deubel, V., Smith, J., Parker, M., Steele, K., et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286 (1999), 2333–2337.
22. [22] Bhatt, S., Gething, P.W., Brady, O.J., Messina, J.P., Farlow, A.W., Moyes, C.L., et al. The global distribution and burden of dengue. Nature 496 (2013), 504–507.
23. [23] Murray, C.L., Jones, C.T., Rice, C.M., Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis. Nat. Rev. Microbiol. 6 (2008), 699–708.
24. [24] Pierson, T.C., Diamond, M.S., Flaviviruses. Knipe, D.M., Howley, P.M., (eds.) Fields Virology, 2013, Lippincott Williams & Wilkins, Wolters Kluwer, Philadelphia, 747–794.
25. [25] Mukhopadhyay, S., Kim, B.S., Chipman, P.R., Rossmann, M.G., Kuhn, R.J., Structure of West Nile virus. Science, 302, 2003, 248.
26. [26] Kuhn, R.J., Zhang, W., Rossmann, M.G., Pletnev, S.V., Corver, J., Lenches, E., et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108 (2002), 717–725.
27. [27] Sirohi, D., Chen, Z., Sun, L., Klose, T., Pierson, T.C., Rossmann, M.G., et al. The 3.8 A resolution cryo-EM structure of Zika virus. Science, 2016.
28. [28] Pierson, T.C., Diamond, M.S., Degrees of maturity: the complex structure and biology of flaviviruses. Curr. Opin. Virol. 2 (2012), 168–175.
29. [29] Mukhopadhyay, S., Kuhn, R.J., Rossmann, M.G., A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 3 (2005), 13–22.
30. [30] Perera-Lecoin, M., Meertens, L., Carnec, X., Amara, A., Flavivirus entry receptors: an update. Virus 6 (2013), 69–88.
31. [31] van der Schaar, H.M., Rust, M.J., Chen, C., van der Ende-Metselaar, H., Wilschut, J., Zhuang, X., et al. Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog., 4, 2008, e1000244.
32. [32] Kalia, M., Khasa, R., Sharma, M., Nain, M., Vrati, S., Japanese encephalitis virus infects neuronal cells through a clathrin-independent endocytic mechanism. J. Virol. 87 (2013), 148–162.
33. [33] Zhu, Y.Z., Xu, Q.Q., Wu, D.G., Ren, H., Zhao, P., Lao, W.G., et al. Japanese encephalitis virus enters rat neuroblastoma cells via a pH-dependent, dynamin and caveola-mediated endocytosis pathway. J. Virol. 86 (2012), 13407–13422.
34. [34] Cruz-Oliveira, C., Freire, J.M., Conceicao, T.M., Higa, L.M., Castanho, M.A., Da Poian, A.T., Receptors and routes of dengue virus entry into the host cells. FEMS Microbiol. Rev. 39 (2015), 155–170.
35. [35] Amara, A., Mercer, J., Viral apoptotic mimicry. Nat. Rev. Microbiol. 13 (2015), 461–469.
36. [36] Pierson, T.C., Kielian, M., Flaviviruses: braking the entering. Curr. Opin. Virol. 3 (2013), 3–12.
37. [37] Stiasny, K., Fritz, R., Pangerl, K., Heinz, F.X., Molecular mechanisms of flavivirus membrane fusion. Amino Acids, 2009.
38. [38] Paul, D., Bartenschlager, R., Flaviviridae replication organelles: oh, what a tangled web we weave. Annu. Rev. Virol. 2 (2015), 289–310.
39. [39] Harak, C., Lohmann, V., Ultrastructure of the replication sites of positive-strand RNA viruses. Virology 479–480 (2015), 418–433.
40. [40] Apte-Sengupta, S., Sirohi, D., Kuhn, R.J., Coupling of replication and assembly in flaviviruses. Curr. Opin. Virol. 9 (2014), 134–142.
41. [41] Cui, L., Lee, Y.H., Kumar, Y., Xu, F., Lu, K., Ooi, E.E., et al. Serum metabolome and lipidome changes in adult patients with primary dengue infection. PLoS Negl. Trop. Dis., 7, 2013, e2373.
42. [42] van Gorp, E.C., Suharti, C., Mairuhu, A.T., Dolmans, W.M., van Der Ven, J., Demacker, P.N., et al. Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever. Clin. Infect. Dis. 34 (2002), 1150–1153.
43. [43] Duran, A., Carrero, R., Parra, B., Gonzalez, A., Delgado, L., Mosquera, J., et al. Association of lipid profile alterations with severe forms of dengue in humans. Arch. Virol. 160 (2015), 1687–1692.
44. [44] Biswas, H.H., Gordon, A., Nunez, A., Perez, M.A., Balmaseda, A., Harris, E., Lower low-density lipoprotein cholesterol levels are associated with severe dengue outcome. PLoS Negl. Trop. Dis., 9, 2015, e0003904.
45. [45] Perera, R., Riley, C., Isaac, G., Hopf-Jannasch, A.S., Moore, R.J., Weitz, K.W., et al. Dengue virus infection perturbs lipid homeostasis in infected mosquito cells. PLoS Pathog., 8, 2012, e1002584.
46. [46] Martin-Acebes, M.A., Merino-Ramos, T., Blazquez, A.B., Casas, J., Escribano-Romero, E., Sobrino, F., et al. The composition of west nile virus lipid envelope unveils a role of sphingolipid metabolism in flavivirus biogenesis. J. Virol. 88 (2014), 12041–12054.
47. [47] Merrill, A.H. Jr., Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chem. Rev. 111 (2011), 6387–6422.
48. [48] Gault, C.R., Obeid, L.M., Hannun, Y.A., An overview of sphingolipid metabolism: from synthesis to breakdown. Adv. Exp. Med. Biol. 688 (2010), 1–23.
49. [49] Carocci, M., Hinshaw, S.M., Rodgers, M.A., Villareal, V.A., Burri, D.J., Pilankatta, R., et al. The bioactive lipid 4-hydroxyphenyl retinamide inhibits flavivirus replication. Antimicrob. Agents Chemother. 59 (2015), 85–95.
50. [50] Kitatani, K., Idkowiak-Baldys, J., Hannun, Y.A., The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell. Signal. 20 (2008), 1010–1018.
51. [51] Aktepe, T.E., Pham, H., Mackenzie, J.M., Differential utilisation of ceramide during replication of the flaviviruses West Nile and dengue virus. Virology 484 (2015), 241–250.
52. [52] Menzel, N., Fischl, W., Hueging, K., Bankwitz, D., Frentzen, A., Haid, S., et al. MAP-kinase regulated cytosolic phospholipase A2 activity is essential for production of infectious hepatitis C virus particles. PLoS Pathog., 8, 2012, e1002829.
53. [53] Mackenzie, J.M., Khromykh, A.A., Parton, R.G., Cholesterol manipulation by West Nile virus perturbs the cellular immune response. Cell Host Microbe 2 (2007), 229–239.
54. [54] Soto-Acosta, R., Mosso, C., Cervantes-Salazar, M., Puerta-Guardo, H., Medina, F., Favari, L., et al. The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in LDL particle uptake and HMG-CoA reductase activity. Virology 442 (2013), 132–147.
55. [55] Hirata, Y., Ikeda, K., Sudoh, M., Tokunaga, Y., Suzuki, A., Weng, L., et al. Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis. PLoS Pathog., 8, 2012, e1002860.
56. [56] Diamond, D.L., Syder, A.J., Jacobs, J.M., Sorensen, C.M., Walters, K.A., Proll, S.C., et al. Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog., 6, 2010, e1000719.
57. [57] Tong, L., Harwood, H.J. Jr., Acetyl-coenzyme A carboxylases: versatile targets for drug discovery. J. Cell. Biochem. 99 (2006), 1476–1488.
58. [58] Asturias, F.J., Chadick, J.Z., Cheung, I.K., Stark, H., Witkowski, A., Joshi, A.K., et al. Structure and molecular organization of mammalian fatty acid synthase. Nat. Struct. Mol. Biol. 12 (2005), 225–232.
59. [59] Smith, S., Witkowski, A., Joshi, A.K., Structural and functional organization of the animal fatty acid synthase. Prog. Lipid Res. 42 (2003), 289–317.
60. [60] Merino-Ramos, T., Vazquez-Calvo, A., Casas, J., Sobrino, F., Saiz, J.C., Martin-Acebes, M.A., Modification of the host cell lipid metabolism induced by hypolipidemic drugs targeting the acetyl coenzyme a carboxylase impairs West Nile virus replication. Antimicrob. Agents Chemother. 60 (2016), 307–315.
61. [61] Heaton, N.S., Perera, R., Berger, K.L., Khadka, S., Lacount, D.J., Kuhn, R.J., et al. Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 17345–17350.
62. [62] Martin-Acebes, M.A., Blazquez, A.B., Jimenez de Oya, N., Escribano-Romero, E., Saiz, J.C., West nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids. PLoS One, 6, 2011, e24970.
63. [63] Tang, W.C., Lin, R.J., Liao, C.L., Lin, Y.L., Rab18 facilitates dengue virus infection by targeting fatty acid synthase to sites of viral replication. J. Virol. 88 (2014), 6793–6804.
64. [64] Rothwell, C., Lebreton, A., Young Ng, C., Lim, J.Y., Liu, W., Vasudevan, S., et al. Cholesterol biosynthesis modulation regulates dengue viral replication. Virology 389 (2009), 8–19.
65. [65] Pena, J., Harris, E., Early dengue virus protein synthesis induces extensive rearrangement of the endoplasmic reticulum independent of the UPR and SREBP-2 pathway. PLoS One, 7, 2012, e38202.
66. [66] Martin-Acebes, M.A., Gabande-Rodriguez, E., Garcia-Cabrero, A.M., Sanchez, M.P., Ledesma, M.D., Sobrino, F., et al. Host sphingomyelin increases West Nile virus infection in vivo. J. Lipid Res. 57 (2016), 422–432.
67. [67] Fraser, J.E., Watanabe, S., Wang, C., Chan, W.K., Maher, B., Lopez-Denman, A., et al. A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection. J. Infect. Dis. 210 (2014), 1780–1791.
68. [68] Blazquez, A.B., Escribano-Romero, E., Merino-Ramos, T., Saiz, J.C., Martin-Acebes, M.A., Stress responses in flavivirus-infected cells: activation of unfolded protein response and autophagy. Front. Microbiol., 5, 2014, 266.
69. [69] Mizushima, N., Levine, B., Cuervo, A.M., Klionsky, D.J., Autophagy fights disease through cellular self-digestion. Nature 451 (2008), 1069–1075.
70. [70] Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., et al. Autophagy regulates lipid metabolism. Nature 458 (2009), 1131–1135.
71. [71] Kaur, J., Debnath, J., Autophagy at the crossroads of catabolism and anabolism. Nat. Rev. Mol. Cell Biol. 16 (2015), 461–472.
72. [72] Heaton, N.S., Randall, G., Dengue virus-induced autophagy regulates lipid metabolism. Cell Host Microbe 8 (2010), 422–432.
73. [73] Mateo, R., Nagamine, C.M., Spagnolo, J., Mendez, E., Rahe, M., Gale, M. Jr., et al. Inhibition of cellular autophagy deranges dengue virion maturation. J. Virol. 87 (2013), 1312–1321.
74. [74] Kimura, T., Jennings, W., Epand, R.M., Roles of specific lipid species in the cell and their molecular mechanism. Prog. Lipid Res. 62 (2016), 75–92.
75. [75] Diwaker, D., Mishra, K.P., Ganju, L., Singh, S.B., Protein disulfide isomerase mediates dengue virus entry in association with lipid rafts. Viral Immunol. 28 (2015), 153–160.
76. [76] Reyes-Del Valle, J., Chavez-Salinas, S., Medina, F., Del Angel, R.M., Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J. Virol. 79 (2005), 4557–4567.
77. [77] Medigeshi, G.R., Hirsch, A.J., Streblow, D.N., Nikolich-Zugich, J., Nelson, J.A., West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbeta3 integrin. J. Virol. 82 (2008), 5212–5219.
78. [78] Zhu, Y.Z., Cao, M.M., Wang, W.B., Wang, W., Ren, H., Zhao, P., et al. Association of heat-shock protein 70 with lipid rafts is required for Japanese encephalitis virus infection in Huh7 cells. J. Gen. Virol. 93 (2012), 61–71.
79. [79] Das, S., Chakraborty, S., Basu, A., Critical role of lipid rafts in virus entry and activation of phosphoinositide 3′ kinase/Akt signaling during early stages of Japanese encephalitis virus infection in neural stem/progenitor cells. J. Neurochem. 115 (2010), 537–549.
80. [80] Puerta-Guardo, H., Mosso, C., Medina, F., Liprandi, F., Ludert, J.E., del Angel, R.M., Antibody-dependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich membrane microdomains. J. Gen. Virol. 91 (2010), 394–403.
81. [81] Lee, C.J., Liao, C.L., Lin, Y.L., Flavivirus activates phosphatidylinositol 3-kinase signaling to block caspase-dependent apoptotic cell death at the early stage of virus infection. J. Virol. 79 (2005), 8388–8399.
82. [82] Meertens, L., Carnec, X., Lecoin, M.P., Ramdasi, R., Guivel-Benhassine, F., Lew, E., et al. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe 12 (2012), 544–557.
83. [83] Jemielity, S., Wang, J.J., Chan, Y.K., Ahmed, A.A., Li, W., Monahan, S., et al. TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. PLoS Pathog., 9, 2013, e1003232.
84. [84] Hamel, R., Dejarnac, O., Wichit, S., Ekchariyawat, P., Neyret, A., Luplertlop, N., et al. Biology of Zika virus infection in human skin cells. J. Virol. 89 (2015), 8880–8896.
85. [85] Richard, A.S., Zhang, A., Park, S.J., Farzan, M., Zong, M., Choe, H., Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 14682–14687.
86. [86] Carnec, X., Meertens, L., Dejarnac, O., Perera-Lecoin, M., Hafirassou, M.L., Kitaura, J., et al. The phosphatidylserine and phosphatidylethanolamine receptor CD300a binds dengue virus and enhances infection. J. Virol. 90 (2015), 92–102.
87. [87] Bhattacharyya, S., Zagorska, A., Lew, E.D., Shrestha, B., Rothlin, C.V., Naughton, J., et al. Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors. Cell Host Microbe 14 (2013), 136–147.
88. [88] Poon, I.K., Lucas, C.D., Rossi, A.G., Ravichandran, K.S., Apoptotic cell clearance: basic biology and therapeutic potential. Nat. Rev. Immunol. 14 (2014), 166–180.
89. [89] Fibriansah, G., Ng, T.S., Kostyuchenko, V.A., Lee, J., Lee, S., Wang, J., et al. Structural changes in dengue virus when exposed to a temperature of 37 degrees C. J. Virol. 87 (2013), 7585–7592.
90. [90] Zhang, X., Sheng, J., Plevka, P., Kuhn, R.J., Diamond, M.S., Rossmann, M.G., Dengue structure differs at the temperatures of its human and mosquito hosts. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 6795–6799.
91. [91] Lanteri, M.C., Diamond, M.S., Law, J.P., Chew, G.M., Wu, S., Inglis, H.C., et al. Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection. PLoS One, 9, 2014, e92134.
92. [92] Miner, J.J., Daniels, B.P., Shrestha, B., Proenca-Modena, J.L., Lew, E.D., Lazear, H.M., et al. The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity. Nat. Med. 21 (2015), 1464–1472.
93. [93] Vazquez-Calvo, A., Saiz, J.C., McCullough, K.C., Sobrino, F., Martin-Acebes, M.A., Acid-dependent viral entry. Virus Res., 2012.
94. [94] Modis, Y., Class II fusion proteins. Adv. Exp. Med. Biol. 790 (2013), 150–166.
95. [95] Stiasny, K., Fritz, R., Pangerl, K., Heinz, F.X., Molecular mechanisms of flavivirus membrane fusion. Amino Acids 41 (2011), 1159–1163.
96. [96] Teissier, E., Pecheur, E.I., Lipids as modulators of membrane fusion mediated by viral fusion proteins. Eur. Biophys. J. 36 (2007), 887–899.
97. [97] Zaitseva, E., Yang, S.T., Melikov, K., Pourmal, S., Chernomordik, L.V., Dengue virus ensures its fusion in late endosomes using compartment-specific lipids. PLoS Pathog., 6, 2010, e1001131.
98. [98] Nour, A.M., Li, Y., Wolenski, J., Modis, Y., Viral membrane fusion and nucleocapsid delivery into the cytoplasm are distinct events in some flaviviruses. PLoS Pathog., 9, 2013, e1003585.
99. [99] Gollins, S.W., Porterfield, J.S., pH-dependent fusion between the flavivirus West Nile and liposomal model membranes. J. Gen. Virol. 67:Pt 1 (1986), 157–166.
100. [100] Moesker, B., Rodenhuis-Zybert, I.A., Meijerhof, T., Wilschut, J., Smit, J.M., Characterization of the functional requirements of West Nile virus membrane fusion. J. Gen. Virol. 91 (2010), 389–393.
101. [101] Stiasny, K., Koessl, C., Heinz, F.X., Involvement of lipids in different steps of the flavivirus fusion mechanism. J. Virol. 77 (2003), 7856–7862.
102. [102] Poh, M.K., Shui, G., Xie, X., Shi, P.Y., Wenk, M.R., Gu, F., U18666 A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication. Antivir. Res. 93 (2012), 191–198.
103. [103] Lee, C.J., Lin, H.R., Liao, C.L., Lin, Y.L., Cholesterol effectively blocks entry of flavivirus. J. Virol. 82 (2008), 6470–6480.
104. [104] Medigeshi, G.R., Hirsch, A.J., Streblow, D.N., Nikolich-Zugich, J., Nelson, J.A., West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbeta3 integrin. J. Virol. 82 (2008), 5212–5219.
105. [105] Umashankar, M., Sanchez-San Martin, C., Liao, M., Reilly, B., Guo, A., Taylor, G., et al. Differential cholesterol binding by class II fusion proteins determines membrane fusion properties. J. Virol. 82 (2008), 9245–9253.
106. [106] Stiasny, K., Heinz, F.X., Effect of membrane curvature-modifying lipids on membrane fusion by tick-borne encephalitis virus. J. Virol. 78 (2004), 8536–8542.
107. [107] Tani, H., Shiokawa, M., Kaname, Y., Kambara, H., Mori, Y., Abe, T., et al. Involvement of ceramide in the propagation of Japanese encephalitis virus. J. Virol. 84 (2010), 2798–2807.
108. [108] Welsch, S., Miller, S., Romero-Brey, I., Merz, A., Bleck, C.K., Walther, P., et al. Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe 5 (2009), 365–375.
109. [109] Gillespie, L.K., Hoenen, A., Morgan, G., Mackenzie, J.M., The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex. J. Virol. 84 (2010), 10438–10447.
110. [110] Miorin, L., Romero-Brey, I., Maiuri, P., Hoppe, S., Krijnse-Locker, J., Bartenschlager, R., et al. Three-dimensional architecture of tick-borne encephalitis virus replication sites and trafficking of the replicated RNA. J. Virol. 87 (2013), 6469–6481.
111. [111] Junjhon, J., Pennington, J.G., Edwards, T.J., Perera, R., Lanman, J., Kuhn, R.J., Ultrastructural characterization and three-dimensional architecture of replication sites in dengue virus-infected mosquito cells. J. Virol. 88 (2014), 4687–4697.
112. [112] Akey, D.L., Brown, W.C., Dutta, S., Konwerski, J., Jose, J., Jurkiw, T.J., et al. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 343 (2014), 881–885.
113. [113] Chang, Y.S., Liao, C.L., Tsao, C.H., Chen, M.C., Liu, C.I., Chen, L.K., et al. Membrane permeabilization by small hydrophobic nonstructural proteins of Japanese encephalitis virus. J. Virol. 73 (1999), 6257–6264.
114. [114] Leon-Juarez, M., Martinez-Castillo, M., Shrivastava, G., Garcia-Cordero, J., Villegas-Sepulveda, N., Mondragon-Castelan, M., et al. Recombinant dengue virus protein NS2B alters membrane permeability in different membrane models. Virol. J., 13, 2016, 1.
115. [115] Miller, S., Kastner, S., Krijnse-Locker, J., Buhler, S., Bartenschlager, R., The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner. J. Biol. Chem. 282 (2007), 8873–8882.
116. [116] Roosendaal, J., Westaway, E.G., Khromykh, A., Mackenzie, J.M., Regulated cleavages at the West Nile virus NS4A-2K-NS4B junctions play a major role in rearranging cytoplasmic membranes and Golgi trafficking of the NS4A protein. J. Virol. 80 (2006), 4623–4632.
117. [117] Colgan, S.M., Hashimi, A.A., Austin, R.C., Endoplasmic reticulum stress and lipid dysregulation. Expert Rev. Mol. Med., 13, 2011, e4.
118. [118] Hsu, N.Y., Ilnytska, O., Belov, G., Santiana, M., Chen, Y.H., Takvorian, P.M., et al. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 141 (2010), 799–811.
119. [119] Reiss, S., Rebhan, I., Backes, P., Romero-Brey, I., Erfle, H., Matula, P., et al. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 9 (2011), 32–45.
120. [120] Vaillancourt, F.H., Pilote, L., Cartier, M., Lippens, J., Liuzzi, M., Bethell, R.C., et al. Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication. Virology 387 (2009), 5–10.
121. [121] Villareal, V.A., Rodgers, M.A., Costello, D.A., Yang, P.L., Targeting host lipid synthesis and metabolism to inhibit dengue and hepatitis C viruses. Antivir. Res. 124 (2015), 110–121.
122. [122] Hurley, J.H., Boura, E., Carlson, L.A., Rozycki, B., Membrane budding. Cell 143 (2010), 875–887.
123. [123] Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319 (2008), 1244–1247.
124. [124] Martinez-Seara, H., Rog, T., Pasenkiewicz-Gierula, M., Vattulainen, I., Karttunen, M., Reigada, R., Interplay of unsaturated phospholipids and cholesterol in membranes: effect of the double-bond position. Biophys. J. 95 (2008), 3295–3305.
125. [125] Roux, A., Cuvelier, D., Nassoy, P., Prost, J., Bassereau, P., Goud, B., Role of curvature and phase transition in lipid sorting and fission of membrane tubules. EMBO J. 24 (2005), 1537–1545.
126. [126] Sot, J., Bagatolli, L.A., Goni, F.M., Alonso, A., Detergent-resistant, ceramide-enriched domains in sphingomyelin/ceramide bilayers. Biophys. J. 90 (2006), 903–914.
127. [127] Goni, F.M., Contreras, F.X., Montes, L.R., Sot, J., Alonso, A., Biophysics (and sociology) of ceramides. Biochem. Soc. Symp., 177-88, 2005.
128. [128] Browman, D.T., Resek, M.E., Zajchowski, L.D., Robbins, S.M., Erlin-1 and erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER. J. Cell Sci. 119 (2006), 3149–3160.
129. [129] Boslem, E., Weir, J.M., MacIntosh, G., Sue, N., Cantley, J., Meikle, P.J., et al. Alteration of endoplasmic reticulum lipid rafts contributes to lipotoxicity in pancreatic beta-cells. J. Biol. Chem. 288 (2013), 26569–26582.
130. [130] Waugh, M.G., Minogue, S., Clayton, E.L., Hsuan, J.J., CDP-diacylglycerol phospholipid synthesis in detergent-soluble, non-raft, membrane microdomains of the endoplasmic reticulum. J. Lipid Res. 52 (2011), 2148–2158.
131. [131] Sano, R., Annunziata, I., Patterson, A., Moshiach, S., Gomero, E., Opferman, J., et al. GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca(2 +)-dependent mitochondrial apoptosis. Mol. Cell 36 (2009), 500–511.
132. [132] Kim, Y.J., Guzman-Hernandez, M.L., Balla, T., A highly dynamic ER-derived phosphatidylinositol-synthesizing organelle supplies phosphoinositides to cellular membranes. Dev. Cell 21 (2011), 813–824.
133. [133] Noisakran, S., Dechtawewat, T., Avirutnan, P., Kinoshita, T., Siripanyaphinyo, U., Puttikhunt, C., et al. Association of dengue virus NS1 protein with lipid rafts. J. Gen. Virol. 89 (2008), 2492–2500.
134. [134] Garcia Cordero, J., Leon Juarez, M., Gonzalez, Y.M.J.A., Cedillo Barron, L., Gutierrez Castaneda, B., Caveolin-1 in lipid rafts interacts with dengue virus NS3 during polyprotein processing and replication in HMEC-1 cells. PLoS One, 9, 2014, e90704.
135. [135] Chen, C.L., Lin, C.F., Wan, S.W., Wei, L.S., Chen, M.C., Yeh, T.M., et al. Anti-dengue virus nonstructural protein 1 antibodies cause NO-mediated endothelial cell apoptosis via ceramide-regulated glycogen synthase kinase-3beta and NF-kappaB activation. J. Immunol. 191 (2013), 1744–1752.
136. [136] Silva, B.M., Sousa, L.P., Gomes-Ruiz, A.C., Leite, F.G., Teixeira, M.M., da Fonseca, F.G., et al. The dengue virus nonstructural protein 1 (NS1) increases NF-kappaB transcriptional activity in HepG2 cells. Arch. Virol. 156 (2011), 1275–1279.
137. [137] Jan, J.T., Chen, B.H., Ma, S.H., Liu, C.I., Tsai, H.P., Wu, H.C., et al. Potential dengue virus-triggered apoptotic pathway in human neuroblastoma cells: arachidonic acid, superoxide anion, and NF-kappaB are sequentially involved. J. Virol. 74 (2000), 8680–8691.
138. [138] Carr, J.M., Kua, T., Clarke, J.N., Calvert, J.K., Zebol, J.R., Beard, M.R., et al. Reduced sphingosine kinase 1 activity in dengue virus type-2 infected cells can be mediated by the 3′ untranslated region of dengue virus type-2 RNA. J. Gen. Virol. 94 (2013), 2437–2448.
139. [139] Jiang, W., Ogretmen, B., Autophagy paradox and ceramide. Biochim. Biophys. Acta 2014 (1841), 783–792.
140. [140] Young, M.M., Kester, M., Wang, H.G., Sphingolipids: regulators of crosstalk between apoptosis and autophagy. J. Lipid Res. 54 (2013), 5–19.
141. [141] Reddy, T., Sansom, M.S., The role of the membrane in the structure and biophysical robustness of the dengue virion envelope. Structure 24 (2016), 375–382.
142. [142] Carro, A.C., Damonte, E.B., Requirement of cholesterol in the viral envelope for dengue virus infection. Virus Res. 174 (2013), 78–87.
143. [143] Zhang, W., Kaufmann, B., Chipman, P.R., Kuhn, R.J., Rossmann, M.G., Membrane curvature in flaviviruses. J. Struct. Biol. 183 (2013), 86–94.
144. [144] Merz, A., Long, G., Hiet, M.S., Brugger, B., Chlanda, P., Andre, P., et al. Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. J. Biol. Chem. 286 (2011), 3018–3032.
145. [145] Callens, N., Brugger, B., Bonnafous, P., Drobecq, H., Gerl, M.J., Krey, T., et al. Morphology and molecular composition of purified bovine viral diarrhea virus envelope. PLoS Pathog., 12, 2016, e1005476.
146. [146] Martinez-Gutierrez, M., Castellanos, J.E., Gallego-Gomez, J.C., Statins reduce dengue virus production via decreased virion assembly. Intervirology 54 (2011), 202–216.
147. [147] Lorizate, M., Brugger, B., Akiyama, H., Glass, B., Muller, B., Anderluh, G., et al. Probing HIV-1 membrane liquid order by Laurdan staining reveals producer cell-dependent differences. J. Biol. Chem. 284 (2009), 22238–22247.
148. [148] Holopainen, J.M., Angelova, M.I., Kinnunen, P.K., Vectorial budding of vesicles by asymmetrical enzymatic formation of ceramide in giant liposomes. Biophys. J. 78 (2000), 830–838.
149. [149] Zha, X., Pierini, L.M., Leopold, P.L., Skiba, P.J., Tabas, I., Maxfield, F.R., Sphingomyelinase treatment induces ATP-independent endocytosis. J. Cell Biol. 140 (1998), 39–47.
150. [150] Walther, T.C., Farese, R.V. Jr., Lipid droplets and cellular lipid metabolism. Annu. Rev. Biochem. 81 (2012), 687–714.
151. [151] Wang, C.W., Lipid droplets, lipophagy, and beyond. Biochim. Biophys. Acta, 2015.
152. [152] Samsa, M.M., Mondotte, J.A., Iglesias, N.G., Assuncao-Miranda, I., Barbosa-Lima, G., Da Poian, A.T., et al. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog., 5, 2009, e1000632.
153. [153] Soto-Acosta, R., Bautista-Carbajal, P., Syed, G.H., Siddiqui, A., Del Angel, R.M., Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus. Antivir. Res. 109 (2014), 132–140.
154. [154] Barletta, A.B., Alves, L.R., Nascimento Silva, M.C., Sim, S., Dimopoulos, G., Liechocki, S., et al. Emerging role of lipid droplets in Aedes aegypti immune response against bacteria and dengue virus. Sci. Rep., 6, 2016, 19928.
155. [155] Helbig, K.J., Carr, J.M., Calvert, J.K., Wati, S., Clarke, J.N., Eyre, N.S., et al. Viperin is induced following dengue virus type-2 (DENV-2) infection and has anti-viral actions requiring the C-terminal end of viperin. PLoS Negl. Trop. Dis., 7, 2013, e2178.
156. [156] Martins, I.C., Gomes-Neto, F., Faustino, A.F., Carvalho, F.A., Carneiro, F.A., Bozza, P.T., et al. The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif. Biochem. J. 444 (2012), 405–415.
157. [157] Teoh, P.G., Huang, Z.S., Pong, W.L., Chen, P.C., Wu, H.N., Maintenance of dimer conformation by the dengue virus core protein alpha4-alpha4′ helix pair is critical for nucleocapsid formation and virus production. J. Virol. 88 (2014), 7998–8015.
158. [158] Carvalho, F.A., Carneiro, F.A., Martins, I.C., Assuncao-Miranda, I., Faustino, A.F., Pereira, R.M., et al. Dengue virus capsid protein binding to hepatic lipid droplets (LD) is potassium ion dependent and is mediated by LD surface proteins. J. Virol. 86 (2012), 2096–2108.
159. [159] Faustino, A.F., Carvalho, F.A., Martins, I.C., Castanho, M.A., Mohana-Borges, R., Almeida, F.C., et al. Dengue virus capsid protein interacts specifically with very low-density lipoproteins. Nanomedicine 10 (2014), 247–255.
160. [160] Iglesias, N.G., Mondotte, J.A., Byk, L.A., De Maio, F.A., Samsa, M.M., Alvarez, C., et al. Dengue virus uses a non-canonical function of the host GBF1-Arf-COPI system for capsid protein accumulation on lipid droplets. Traffic 16 (2015), 962–977.
161. [161] Suthar, M.S., Diamond, M.S., Gale, M. Jr., West Nile virus infection and immunity. Nat. Rev. Microbiol. 11 (2013), 115–128.
162. [162] Devignot, S., Sapet, C., Duong, V., Bergon, A., Rihet, P., Ong, S., et al. Genome-wide expression profiling deciphers host responses altered during dengue shock syndrome and reveals the role of innate immunity in severe dengue. PLoS One, 5, 2010, e11671.
163. [163] Ghoshal, A., Das, S., Ghosh, S., Mishra, M.K., Sharma, V., Koli, P., et al. Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia 55 (2007), 483–496.
164. [164] Verma, S., Kumar, M., Nerurkar, V.R., Cyclooxygenase-2 inhibitor blocks the production of West Nile virus-induced neuroinflammatory markers in astrocytes. J. Gen. Virol. 92 (2011), 507–515.
165. [165] Calvert, J.K., Helbig, K.J., Dimasi, D., Cockshell, M., Beard, M.R., Pitson, S.M., et al. Dengue virus infection of primary endothelial cells induces innate immune responses, changes in endothelial cells function and is restricted by interferon-stimulated responses. J. Interf. Cytokine Res. 35 (2015), 654–665.
166. [166] Clarke, J.N., Davies, L.K., Calvert, J.K., Gliddon, B.L., Shujari, W.H., Aloia, A.L., et al. Reduction in sphingosine kinase 1 influences the susceptibility to dengue virus infection by altering antiviral responses. J. Gen. Virol. 97 (2016), 95–109.
167. [167] Chen, C.J., Ou, Y.C., Chang, C.Y., Pan, H.C., Lin, S.Y., Liao, S.L., et al. Src signaling involvement in Japanese encephalitis virus-induced cytokine production in microglia. Neurochem. Int. 58 (2011), 924–933.
168. [168] Hoenen, A., Liu, W., Kochs, G., Khromykh, A.A., Mackenzie, J.M., West Nile virus-induced cytoplasmic membrane structures provide partial protection against the interferon-induced antiviral MxA protein. J. Gen. Virol. 88 (2007), 3013–3017.
169. [169] Hoenen, A., Gillespie, L., Morgan, G., van der Heide, P., Khromykh, A., Mackenzie, J., The West Nile virus assembly process evades the conserved antiviral mechanism of the interferon-induced MxA protein. Virology 448 (2014), 104–116.
170. [170] Munger, J., Bennett, B.D., Parikh, A., Feng, X.J., McArdle, J., Rabitz, H.A., et al. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat. Biotechnol. 26 (2008), 1179–1186.
171. [171] Garavito, R.M., Mulichak, A.M., The structure of mammalian cyclooxygenases. Annu. Rev. Biophys. Biomol. Struct. 32 (2003), 183–206.
172. [172] Opie, L.H., Present status of statin therapy. Trends Cardiovasc. Med. 25 (2015), 216–225.
173. [173] Menendez, J.A., Lupu, R., Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 7 (2007), 763–777.
174. [174] Martinez-Gutierrez, M., Correa-Londono, L.A., Castellanos, J.E., Gallego-Gomez, J.C., Osorio, J.E., Lovastatin delays infection and increases survival rates in AG129 mice infected with dengue virus serotype 2. PLoS One, 9, 2014, e87412.
175. [175] Whitehorn, J., Nguyen, C.V., Khanh, L.P., Kien, D.T., Quyen, N.T., Tran, N.T., et al. Lovastatin for the treatment of adult patients with dengue: a randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 62 (2016), 468–476.
176. [176] Faustino, A.F., Guerra, G.M., Huber, R.G., Hollmann, A., Domingues, M.M., Barbosa, G.M., et al. Understanding dengue virus capsid protein disordered N-terminus and pep14-23-based inhibition. ACS Chem. Biol. 10 (2015), 517–526.
177. [177] Jeffries, C.L., Walker, T., The potential use of Wolbachia-based mosquito biocontrol strategies for Japanese encephalitis. PLoS Negl. Trop. Dis., 9, 2015, e0003576.
178. [178] Jeffries, C.L., Walker, T., Biocontrol strategies for arboviral diseases and the potential influence of resident strains in mosquitoes. Curr. Trop. Med. Rep. 3 (2016), 20–25.
179. [179] Molloy, J.C., Sommer, U., Viant, M.R., Sinkins, S.P., Wolbachia modulates lipid metabolism in Aedes albopictus mosquito cells. Appl. Environ. Microbiol., 2016.
180. [180] Krishnan, M.N., Garcia-Blanco, M.A., Targeting host factors to treat West Nile and dengue viral infections. Virus 6 (2014), 683–708.
181. [181] Acosta, E.G., Kumar, A., Bartenschlager, R., Revisiting dengue virus-host cell interaction: new insights into molecular and cellular virology. Adv. Virus Res. 88 (2014), 1–109.
182. [182] Roby, J.A., Setoh, Y.X., Hall, R.A., Khromykh, A.A., Post-translational regulation and modifications of flavivirus structural proteins. J. Gen. Virol. 96 (2015), 1551–1569.
183. [183] Fu, Q., Inankur, B., Yin, J., Striker, R., Lan, Q., Sterol carrier protein 2, a critical host factor for dengue virus infection, alters the cholesterol distribution in mosquito Aag2 cells. J. Med. Entomol. 52 (2015), 1124–1134.
184. [184] Uchida, L., Urata, S., Ulanday, G.E., Takamatsu, Y., Yasuda, J., Morita, K., et al. Suppressive effects of the site 1 protease (S1P) inhibitor, PF-429242, on dengue virus propagation. Virus, 8, 2016.
185. [185] Vazquez-Calvo, A., Saiz, J.C., Sobrino, F., Martin-Acebes, M.A., Inhibition of enveloped virus infection of cultured cells by valproic acid. J. Virol. 85 (2011), 1267–1274.
186. [186] Faustino, A.F., Martins, I.C., Carvalho, F.A., Castanho, M.A., Maurer-Stroh, S., Santos, N.C., Understanding dengue virus capsid protein interaction with key biological targets. Sci. Rep., 5, 2015, 10592.